AscellaHealth Showcases Rare Disease Expertise and Comprehensive Specialty Pharmaceutical Solutions at World Orphan Drug Congress USA 2025

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

BERWYN, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, proudly announces its role as a Silver Sponsor at the World Orphan Drug Congress USA (WODC), taking place April 22-24, 2025, at the Boston Convention Center. The company will highlight its innovative specialty pharmaceutical solutions for life science companies, designed to enhance patient access to specialty products for individuals with complex, chronic and rare diseases.

Attendees are invited to join Donovan Quill, EVP of Life Science Strategies at AscellaHealth, for a roundtable discussion on April 23 at 2pm, titled The Truths and Myths of Building a Patient-First Exclusive Distribution Program. Quill will lead an interactive session that delves into the realities and benefits of an exclusive distribution model for specialty pharmaceuticals. The roundtable will provide valuable insights into the exclusive distribution approach:

  • Improves oversight and control over supply chain processes, ensuring more reliable and efficient delivery of medications to patients.
  • Generates cost savings through inventory management and distribution fees while promoting operational efficiency.
  • Provides access to comprehensive data and insights into the patient experience, supporting more informed decision-making.

WODC also offers conference participants the opportunity to meet AscellaHealth industry experts at booth #527 and learn about our innovative, end-to-end solutions that support life sciences companies with tailored commercialization, market access and distribution strategies.

"This conference is the perfect forum to engage with forward-thinking leaders across the industry”, says Quill. “My hope is that our roundtable will spark meaningful discussion and clear up the many myths around exclusive distribution as well as provide actionable strategies that truly put patients first while optimizing supply chain performance."

To schedule a 1:1 meeting please contact businessdevelopment@ascellahealth.com or connect with us using the event app.

About AscellaHealth LLC
AscellaHealth is a global partner that delivers proven end-to-end solutions to both life sciences and healthcare companies to enhance the quality of life for patients with complex, chronic conditions. A dedicated team gets critical healthcare products from manufacturers to patients while ensuring an efficient flow of funds between payers and pharma. For more information on our services and solutions, visit www.AscellaHealth.com.


Media:
Nicole Dufour
CPR Communications
ndufour@cpronline.com
201.641.1911 x 54

Primary Logo

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.70
+0.00 (0.00%)
AAPL  263.40
+0.00 (0.00%)
AMD  278.26
+0.00 (0.00%)
BAC  53.51
+0.00 (0.00%)
GOOG  332.77
+0.00 (0.00%)
META  676.87
+0.00 (0.00%)
MSFT  420.26
+0.00 (0.00%)
NVDA  198.35
+0.00 (0.00%)
ORCL  178.34
+0.00 (0.00%)
TSLA  388.90
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.